Renal tubular drug transporters

Nephron - Physiology

Volumn 103, Issue 3, 2006, Pages

  Launay Vacher, Vincent ^a   Izzedine, Hassane ^a   Karie, Svetlana ^a   Hulot, Jean Sébastien ^a   Baumelou, Alain ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Multidrug resistant associated proteins; Organic anion transporters; Organic anion transporting polypeptides; Organic cation transporters; P glycoprotein; PEPT; Proximal tubular cells

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; BUMETANIDE; CIDOFOVIR; CIMETIDINE; DIGOXIN; ELECTROLYTE; ESTRONE SULFATE; FUROSEMIDE; GLYCOPROTEIN P; GUANIDINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; OCHRATOXIN; ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER; ORGANIC COMPOUND; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; PIROXICAM; POLYCYCLIC AROMATIC HYDROCARBON; PROBENECID; PROSTAGLANDIN E2; QUININE; TETRYLAMMONIUM; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; URATE;

DRUG DISPOSITION; DRUG ELIMINATION; DRUG EXCRETION; DRUG TRANSPORT; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EPITHELIUM; KIDNEY TUBULE EXCRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; SHORT SURVEY; TOXICOKINETICS;

ANIMALS; CARRIER PROTEINS; HUMANS; KIDNEY TUBULES;

EID: 33745437964     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092212     Document Type: Short Survey

References (143)

1. Marshall EK, Vickers L: The mechanism of the elimination of phenolsulphonphtalein by kidney - a proof of secretion by the convoluted tubules. Bull Johns Hopkins Hosp 1923;34:1-6.
2. Schmith HW, Goldring W, Chassis H: The measurement of the tubular excretory mass, effective blood flow, and filtration rate in the normal human kidney. J Clin Invest 1938;17:263-278.
3. Beyer KH, Russo HF, Tillson EK, Miller AK, Verwey WF, Gass SR: 'Benemid' p-(di-n-propylsulfamyl)-benzoic acid: its renal affinity and its elimination. Am J Physiol 1951;166:625-640.
4. Lacy SA, Hitchcock MJ, Lee WA, Tellier P, Cundy KC: Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys. Toxicol Sci 1998;44:97-106.
5. Roch-Ramel F, Besseghir K, Murer H: Renal excretion and tubular transport of organic anions and cations; in Windhager EE (ed): Renal Physiology, Handbook of Physiology, ed 2. New York, Oxford University Press, 1992, pp 2189-2262.
6. Ullrich KJ: Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. Biochim Biophys Acta 1994;1197:45-62.
7. Pritchard JB, Miller DS: Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 1993;73:765-796.
8. Pritchard JB, Miller DS: Comparative insights into the mechanisms of renal organic anion and cation secretion. Am J Physiol 1991;261:R1329-R1340.
9. Pritchard JB, Miller DS: Renal secretion of organic anions and cations. Kidney Int 1996;49:1649-1654.
10. Inui K, Okuda M: Cellular and molecular mechanisms of renal tubular secretion of organic anions and cations. Exp Nephrol 1998;2:100-108.
11. Roch-Ramel F: Renal transport of organic anions. Curr Opin Nephrol Hypertens 1998;7:517-524.
12. Koepsell H: Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 1998;60:243-266.
13. Koepsell H, Gorboulev V, Arndt P: Molecular pharmacology of organic cation transporters in kidney. J Membr Biol 1999;167:103-117.
14. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-269.
15. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735-7738.
16. Schaub TP, Kartenbeck J , Konig J, Vogel O, Witzgall R, Kritz W, Keppler D: Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 1997;8:1213-1221.
17. Cool M, Jolicoeur P: Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice. Cancer Res 1999;59:2438-2444.
18. Inui K, Terada T: Dipeptide transporters; in Amidon G, Sadee W (eds): Membrane Transporters as Drug Targets. New York, Kluwer Academic/Prenum Publishers, 1999, pp 269-288.
19. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H: Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997;272:18526-18529.
20. Sweet DH, Wolff NA, Pritchard JB: Expression cloning and characterization of ROAT1: the basolateral organic anion transporter in rat kidney. J Biol Chem 1997;272:30088-30095.
21. Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, Endou H: Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 1999;10:464-471.
22. Uwai Y, Okuda M, Takami K, Hashimoto Y, Inui K: Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett 1998;438:321-324.
23. Jariyawat S, Sekine T, Takeda M, Apiwattanakul N, Kanai Y et al: The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther 1999;290:672-677.
24. Apiwattanakul N, Sekine T; Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H: Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol 1999;55:847-854.
25. Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, Endou H: Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 2000;294:844-849.
26. Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH: The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol 1999;56:570-580.
27. Tsuda M, Sekine T, Takeda M, Cha SH, Kanai Y, Kimura M, Endou H: Transport of ochratoxin A by renal multispecific organic anion transporter 1. J Pharmacol Exp Ther 1999;289:1301-1305.
28. Bahn A, Prawitt D, Buttler D, Reid G, Enklaar T, Wolff NA, Ebbinghaus C, Hillemann A, Schulten HJ, Gunawan B, Fuzesi L, Zabel B, Burckhardt G: Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene. Biochem Biophys Res Commun 2000;275:623-630.
29. Hosoyamada M, Sekine T, Kanai Y, Endou H: Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999;276:F122-F128.
30. Reid G, Wolff NA, Dautzenberg FM, Burckhardt G: Cloning of a human renal p-aminohippurate transporter, hROAT1. Kid Blood Press Res 1998;21:233-237.
31. Lu R, Chan BS, Schuster VL: Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol 1999;276:F295-F303.
32. Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 1999;255:508-514.
33. 3 Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H: Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 1998;429:179-182.
34. Sun W, Wu RR, van Poelje PD, Erion MD: Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 2001;283:417-422.
35. Kusuhara H, Sekine T, Utsunomiya TN, Tsuda M, Kojima R, Cha SH, Sugiyamam Y, Kanai Y, Endou H: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999;274:13675-13680.
36. Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, Endou H: Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001;59:1277-1286.
37. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999;274:13675-13680.
38. Deguchi T, Kusuhara H, Takadate A, Endou H, Otagiri M, Sugiyama Y: Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 2004;65:162-174.
39. Sekine T, Cha SH, Endou H: The multispecific organic anion transporter (OAT) family. Pflügers Arch 2000;440:337-350.
40. Kawai J, Shinagawa A, Shibata K et al: Functional annotation of a full-length mouse cDNA collection. Nature 2001;409:685-690.
41. Bergwerk AJ, Shi X, Ford AC, Kanai N, Jacquemin E, Burk RD, Bai S, Novikoff PM, Stieger B, Meier PJ, Schuster VL, Wolkoff AW: Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am J Physiol 1996;271:G231-G238.
42. Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ: Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc Natl Acad Sci USA 1994;91:133-137.
43. Kanai N, Lu R, Bao Y, Wolkoff AW, Schuster VL: Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates. Am J Physiol 1996;270:F319-F325.
44. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, et al: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other AOTPs of human liver. Gastroenterology 2001;120:525-533.
45. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 2000;273:251-260.
46. Noe B, Hagenbuch B, Stieger B, Meier PJ: Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA 1997;94:10346-10350.
47. Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H, Yawo H: Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 1998;273:22395-22401.
48. Walters HC, Craddock AL, Fusegawa H, Willingham MC, Dawson PA: Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am J Physiol 2000;279:G1188-G1200.
49. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, et al: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Common 2000;273:251-260.
50. Saito H, Masuda S, Inui K: Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 1996;271:20719-20725.
51. Masuda S, Takeuchi A, Saito H, Hashimoto Y, Inui K: Functional analysis of rat renal organic anion transporter OAT-K1:bidirectional methotrexate transport in apical membrane. FEBS Lett 1999;459:128-132.
52. Masuda S, Saito H, Inui KI: Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1. J Pharmacol Exp Ther 1997;283:1039-1042.
53. Choudhuri S, Ogura K, Klaassen CD: Cloning, expression, and ontogeny of mouse organic anion-transporting polypeptide-5, a kidney-specific organic anion transporter. Biochem Biophys Res Commun 2001;280:92-98.
54. Cole SPC, Bhardwaj G, Gerlach JH, MacKie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-1654.
55. 5 Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, Sartorelli AC: Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 1997;57:5238-5242.
56. Wijnholds J, Evers R, van Leusden MR, Mol CA, Zaman GJ, Mayer U, Beijnen JH, van der Valk M, Krimpenfort P, Borst P: Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 1997;3:1275-1279.
57. Zaman GJ, Versantvoort CH, Smit JJ, Eijdems EW, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EG, Baas F, et al: Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747-1750.
58. Wijnholds J, Scheffer GL, van der Valk M, van der Valk P, Beijnen JH, Scheper RJ, Borst P: Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. J Exp Med 1998;188:797-808.
59. Peng K-C, Cluzeaud F, Bens M, Duong van Huyen JP, Wioland MA, et al: Tissue and cell distribution of the multidrug resistance-associated protein (MRP) on mouse intestine and kidney. J Histochem Cytochem 1999;47:757-767.
60. Konig J, Nies AT, Cui Y, Leier I, Keppler D: Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999;1461:377-394.
61. Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, Borst P: Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 2000;83:375-383.
62. Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P: Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer 2000;83:366-374.
63. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, Oude Elferink RP: Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 1999;338:393-401.
64. Rappa G, Lorico A, Flavell RA, Sartorelli AC: Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 1997;57:5232-5237.
65. Loe DW, Stewart RK, Massey TE, Deeley RG, Cole SP: ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol Pharmacol 1997;51:1034-1041.
66. Loe DW, Deeley RG, Cole SP: Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 1998;58:5130-5136.
67. Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P: Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 1995;92:7690-7694.
68. Oude Elferink RPJ, Jansen PLM: The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther 1994;64:77-97.
69. Schaub TP, Kartenbeck J, Konig J, Vogel O, Witzgall R, Kriz W, Keppler D: Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 1997;8:1213-1221.
70. Keppler D, König J: Expression and localisation of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 1997;11:509-516.
71. Mottino AD, Hoffman T, Jennes L, Vore M: Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther 2000;293:717-723.
72. Van Aubel RA, Hartog A, Bindels RJ, Van Os CH, Russel FG: Expression and immunolocalization of multidrug resistance protein 2 in rabbit small intestine. Eur J Pharmacol 2000;400:195-198.
73. Wada M, Toh S, Taniguchi K, Nakamura T, Uchiumi T, Kohno K, Yoshida I, Kimura A, Sakisaka S, Adachi Y, Kuwano M: Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/ Dubin-Johnson syndrome. Hum Mol Genet 1998;7:203-207.
74. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D: Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999;55:929-937.
75. Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH, Borst P: Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 1998;101:1310-1319.
76. Kawabe T, Chen ZS, Wada M, Uchiumi T, Ono M, Akiyama S, Kuwano M: Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett 1999;456:327-331.
77. Demeule M, Brossard M, Beliveau R: Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 1999;297:F832-F840.
78. Laouari D, Yang R, Veau C, Blanke I, Friedlander G: Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am J Physiol 2001;280:F636-F645.
79. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997;57:3537-3547.
80. Kiuchi Y, Suzuki H, Hirohashi T, Tyson CA, Sugiyama Y: cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett 1998;433:149-152.
81. Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ, Jansen G, Peters GJ, Ponne N, Scheper RJ, Elferink RP, Baas F, Borst P: MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 1999;96:6914-6919.
82. Konig J, Rost D, Cui Y, Keppler D: Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999;29:1156-1163.
83. Russel FG, Masereeuw R, van Aubel RA: Molecular aspects of renal anionic drug transport. Annu Rev Physiol 2002;64:563-594.
84. Hirohashi T, Suzuki H, Sugiyama Y: Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 1999;274:15181-15185.
85. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, Sugiyama Y: Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 1998;53:1068-1075.
86. van Aubel RA, Smeets PH, Peters JG, Bindels RJ, Russel FG: The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 2002;13:595-603.
87. Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Fridland A: MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 1999;5:1048-1051.
88. Lee K, Klein-Szanto AJ, Kruh GD: Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J Natl Cancer Inst 2000;92:1934-1940.
89. Strewler GJ: Release of cAMP from a renal epithelial cell line. Am J Physiol 1984;246:C224-C230.
90. Chevallier RL, Fang GD, Garmey M: Extracellular cGMP inhibits transepithelial sodium transport by LLC-PK1 renal tubular cells. Am J Physiol 1996;270:F283-F288.
91. Broadus AE, Kaminsky NI, Hardman JG, Sutherland EW, Liddle GW: Kinetic parameters and renal clearances of plasma adenosine 3′,5′- monophosphate and guanosine 3′,5′-monophosphate in man. J Clin Invest 1970;49:2222-2236.
92. Mc Aleer MA, Breen MA, White NL, Matthews N: pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem 1999;274:23541-23548.
93. Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P: Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA 2000;97:7476-7481.
94. Jedlitschky G, Burshell B, Keppler D: The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem 2000;275:30069-30074.
95. Geary CA, Goy MF, Boucher RC: Synthesis and vectorial export of cGMP in airway epithelium: expression of soluble and CNP-specific guanylate cyclases. Am J Physiol 1993;265:L598-L605.
96. Boom A, Golstein PE, Frerotte M, Sande JV, Beauwens R: Inhibition of basolateral cAMP permeability in the toad urinary bladder. J Physiol 2000;528:189-198.
97. Madon J, Hagenbuch B, Landmann L, Meier PJ, Stieger B: Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 2000;57:634-641.
98. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, Swart J, Kool M, van Soest S, Baas F, ten Brink JB, de Jong PT: Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000;25:228-231.
99. Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J: Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 2000;97:6001-6006.
100. Laouari D, Yang R, Veau C, Blanke I, Friedlander G: Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am J Physiol 2001;280:F636-F645.
101. Acara M, Roche-Ramel F, Rennick B: Bidirectional renal tubular transport of free choline: a micropuncture study. Am J Physiol 1979;236:F112-F118.
102. MacKinney TD: Heterogeneity of organic base secretion by proximal tubules. Am J Physiol 1982;245:F404-F407.
103. Steen H, Merema M, Meijer DK: A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liver. Biochem Pharmacol 1992;44:2323-2331.
104. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H: Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994;372:549-552.
105. Urakami Y, Nakamura N, Takahashi K, Okuda M, Saito H, Hashimoto Y, Inui K: Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Lett 1999;461:339-342.
106. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A: Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997;419:107-111.
107. Wu X, Prasad PD, Leibach FH, Ganapathy V: cDNA sequence, transport function, and genomic organization of human OCTN2. a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998;246:589-595.
108. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A: Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998;273:20378-20382.
109. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V: Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999;290:1482-1492.
110. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A: Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 1999;21:91-94.
111. Tang NL, Ganapathy V, Wu X, Hui J, Seth P, Yuen PM, Wanders RJ, Fok TF, Hjelm NM: Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet 1999;8:655-660.
112. Lamhonwah AM, Skaug J, Scherer SW, Tein I: A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem Biophys Res Commun 2003;301:98-101.
113. Wang Y, Ye J, Ganapathy V, Longo N: Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 1999;96:2356-2360.
114. Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E: Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 2003;14:1889-1896.
115. Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H: Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 2002;13:1847-1854.
116. Asano T, Takahashi KA, Fujioka M, Inoue S, Okamoto M, Sugioka N, Nishino H, Tanaka T, Hirota Y, Kubo T: ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. Pharmacogenetics 2003;13:675-682.
117. Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R: Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 1992;263:840-845.
118. Leibach FH, Ganapathy V: Peptide transporters in the intestine and the kidney. Annu Rev Nutr 1996;16:99-119.
119. Shen H, Smith DE, Yang T, Huang YG, Schnermann JB, Brosius FC 3rd: Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol 1999;276:F658-F665.
120. +/peptide cotransporter in rat digestive tract. Biochem Biophys Res Commun 1996;220:848-852.
121. Doring F, Walter J, Will J, Focking M, Boll M, Amasheh S, Clauss W, Daniel H: Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Invest 1998;101:2761-2767.
122. Hori R, Tomita Y, Katsura T, Yasuhara M, Inui K, Takano M: Transport of bestatin in rat renal brush-border membrane vesicles. Biochem Pharmacol 1993;45:1763-1768.
123. Ganapathy ME, Huang W, Wang H, Ganapathy V, Leibach FH: Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun 1998;246:470-475.
124. Swaan PW, Stehouwer MC, Tukker JJ: Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril. Biochim Biophys Acta 1995;1236:31-38.
125. Temple CS, Boyd CA: Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter. Biochim Biophys Acta 1998;1373:277-281.
126. Ganapathy ME, Brandsch M, Prasad PD, Ganapathy V, Leibach FH: Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J Biol Chem 1995;270:25672-25677.
127. Ganapathy ME, Prasad PD, Mackenzie B, Ganapathy V, Leibach FH: Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2. Biochim Biophys Acta 1997;1324:296-308.
128. Wenzel U, Gebert I, Weintraut H, Weber WM, Clauss W, Daniel H: Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. J Pharmacol Exp Ther 1996;277:831-839.
129. Han HK, Oh DM, Amidon GL: Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPTq cells overexpressing a human peptide transporter. Pharm Res 1998;15:1382-1386.
130. Fanning AS, Anderson JM: PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 1999;103:767-772.
131. Gisler SM, Stagljar I, Traebert M, Bacic D, Biber J, Murer H: Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 2001;276:9206-9213.
132. Fouassier L, Duan CY, Feranchak AP, Yun CH, Sutherland E, Simon F, Fitz JG, Doctor RB: Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 2001;33:166-176.
133. Bush AE, Schuster A, Waldegger S, Wagner CA, Zempel G, et al: Expression of a renal type I sodium/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. Proc Natl Acad Sci USA 1996;93:5347-5351.
134. Uchino H, Tamai I, Yabuuchi H, China K, Miyamoto K, Takeda E, Tsuji A: Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1. Antimicrob Agents Chemother 2000;44:574-577.
135. Yabuuchi H, Tamai I, Morita K, Kouda T, Miyamoto K, Takeda E, Tsuji A: Hepatic sinusoidal membrane transport of anionic drugs mediated by anion transporter Npt1. J Pharmacol Exp Ther 1998;286:1391-1396.
136. Bonate PL, Reith K, Weir S: Drug interactions at the renal level. Implications for drug development. Clin Pharmacokinet 1998;34:375-404.
137. Jaehde U, Sorgel F, Reiter A, Sigl G, Naber KG, Schunack W: Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin Pharmacol Ther 1995;58:532-541.
138. Muirhead MR, Somogyi AA: Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney. Drug Metab Dispos 1991;19:312-316.
139. Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R: Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 1992;263:840-845.
140. Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, Sasayama S, Inui K: Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin Pharmacol Ther 1998;64:123-128.
141. Product Information: Benemid®, Probenecid. West Point, Merck & Co., 1997.
142. Jacobs C, Kaubisch S, Halsey J, Lum BL, Gosland M, Coleman CL, Sikic BI: The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 1991;67:1518-1524.
143. Product Information: Vistide®, cidofovir injection. Foster City, Gilead Sciences, 1997.